AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss

RecruitingNAAges 18 Years - anyAllUniversity of Illinois at Chicago
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to investigate the relationship between thigh strength and walking ability and assess if using a blood pressure cuff on the leg improves strength and walking performance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * At least 18 years old * History of lower limb unilateral transfemoral amputation. * At least two years post lower limb amputation * Able to ambulate independently without the use of aids (i.e., walking cane). * Able to walk at least 10 minutes continuously without stopping. * Has a safe residuum with no open wounds on either the residual or intact limb. * Has a prosthetic limb with materials that are sound and safe to withstand the mobility requirements of the study. Exclusion Criteria: * Younger than 18 years old. * Inability to give informed consent. * Neurological disorder that affects gait. * Participants with significant metal (greater than one orthopaedic screw) in either the residual limb or the sound/intact limb * Participants who begin taking medications or change dosage of medications that could affect gait, balance, and cardiovascular function during the course of the study. * Currently pregnant (or intend to become pregnant while participating in study). * History of any condition where fatiguing contractions or resisted leg contractions are contraindicated. * Blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg). * History of uncontrolled hypertension. * History of heart failure. * Head injury within the previous 6 months. * Seizure disorder. * History of vascular disease. * History of thrombosis. * History of sickle cell trait. * History of genetic disease
๐Ÿ’Š

What it tests

  • Ischemic Preconditioning
๐Ÿ“

Where

1 site
UIC Physical Therapy Faculty Practice
Chicago, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy